{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T22:46:32Z","timestamp":1777761992659,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["132119"],"award-info":[{"award-number":["132119"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI46749"],"award-info":[{"award-number":["U01AI46749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI068633"],"award-info":[{"award-number":["U01AI068633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["51794"],"award-info":[{"award-number":["51794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001342","name":"Department of Science and Technology, Republic of South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.antiviral.2013.06.019","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T19:01:49Z","timestamp":1372964509000},"page":"405-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: Results from the CAPRISA 004 trial"],"prefix":"10.1016","volume":"99","author":[{"given":"Cheryl","family":"Baxter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonhlanhla","family":"Yende-Zuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phindile","family":"Tshabalala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quarraisha","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S.","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.06.019_b0065","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"On behalf of the caprisa 004 trial group. Effectiveness and safety of tenofovir gel an antiretroviral microbicide for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.06.019_b0070","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/cid\/cit145","article-title":"Prophylactic effect of antiretroviral therapy on hepatitis b virus infection","volume":"56","author":"Gatanaga","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.06.019_b0075","doi-asserted-by":"crossref","first-page":"e55013","DOI":"10.1371\/journal.pone.0055013","article-title":"MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments","volume":"8","author":"Hendrix","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.06.019_b0080","article-title":"Protective effect of hepatitis b virus-active cART against primary hepatitis b virus infection [abstract #33], 20th Conference on Opportunistic Infections and Retroviruses","author":"Heuft","year":"2013","journal-title":"Atlanta"},{"key":"10.1016\/j.antiviral.2013.06.019_b0085","unstructured":"Kashuba, A., 2008. Genital Compartmentalization of Orally and Topically Administered Antiretrovirals, 15th Conference on Opportunistic Infections and Retroviruses, Boston."},{"key":"10.1016\/j.antiviral.2013.06.019_b0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.51.4.597","article-title":"Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B","volume":"51","author":"Lim","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2013.06.019_b0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/QAD.0b013e3282f303bf","article-title":"Interruptions of tenofovir\/emtricitabine-based antiretroviral therapy in patients with HIV\/hepatitis B virus co-infection","volume":"22","author":"Nuesch","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.06.019_b0100","doi-asserted-by":"crossref","first-page":"s65","DOI":"10.1016\/j.jhep.2005.11.015","article-title":"Natural history of chronic hepatitis B in co-infected patients","volume":"44","author":"Puoti","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.06.019_b0105","doi-asserted-by":"crossref","first-page":"e25974","DOI":"10.1371\/journal.pone.0025974","article-title":"A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel","volume":"6","author":"Schwartz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.06.019_b0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3851\/IMP2311","article-title":"Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 trial","volume":"18","author":"Sokal","year":"2013","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2013.06.019_b0115","unstructured":"WHO\/UNAIDS, 2010. Next steps with 1% Tenofovir Gel \u2013 Meeting Report 25\u201326 August 2010, Johannesburg, South Africa. Joint United Nations Programme on HIV\/AIDS, Geneva, Switzerland."},{"key":"10.1016\/j.antiviral.2013.06.019_b0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/QAI.0b013e3182253c19","article-title":"Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa","volume":"58","author":"Williams","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421300185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421300185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:24:48Z","timestamp":1777472688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421300185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S016635421300185X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.06.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: Results from the CAPRISA 004 trial","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}